FDP
RPRX icon

Financiere des Professionnels’s Royalty Pharma RPRX Stock Holding History

Financiere des Professionnels’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
32,413
+4,356
+16% +$191K 0.09% 167
2025
Q4 		$1.08M Buy
28,057
+1,601
+6% +$61.1K 0.06% 182
2025
Q3 		$933K Buy
+26,456
New +$958K 0.05% 182
2024
Q2 		– Sell
-32,931
Closed -$1M – 152
2024
Q1 		$1M Buy
+32,931
New +$971K 0.08% 124

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Financiere des Professionnels's RPRX Position: Q1 2026 in Review

Financiere des Professionnels increased its Royalty Pharma (RPRX) stake by 16% in Q1 2026, buying an estimated $191K and bringing the position to 32,413 shares worth $1.55M. The position accounts for 0.09% of the portfolio, ranked #167.

Financiere des Professionnels first reported a position in RPRX in Q1 2024 and has held it in 4 quarters since. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Financiere des Professionnels held 32,413 shares of Royalty Pharma worth $1.55M as of Q1 2026.
  • Financiere des Professionnels bought 4,356 Royalty Pharma shares in Q1 2026, an estimated $191K.
  • Royalty Pharma made up 0.09% of Financiere des Professionnels's portfolio in Q1 2026, its #167 holding.
  • Financiere des Professionnels first reported a position in Royalty Pharma in Q1 2024 and has held it in 4 quarters since.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.